Ms. Linda Sampson reports

MARAPHARM VENTURES INC. ANNOUNCES THAT IT HAS BEEN INCLUDED IN THE CSE25, AN INDEX COMPRISED OF THE LARGEST COMPANIES TRADING ON THE CSE

Marapharm Ventures Inc. has qualified for the CSE25 Index on the Canadian Securities Exchange.

On Sept. 18, 2017, the CSE announced the introduction of a new index comprising the securities of the largest companies trading on the exchange.

The CSE25 Index is a subgroup of the CSE Composite Index. The new index includes the top 25 securities by market capitalization contained in the composite index. These companies account for over 50 per cent of the weighting in the larger index and are typically stocks that attract considerable trading volume.

"Marapharm is pleased to be included in a benchmark that gauges our market performance and liquidity as one of the CSE's largest companies," said Linda Sampson, Marapharm chief executive officer.

About Marapharm Ventures Inc.

Marapharm is a publicly traded company primarily investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 it has rapidly expanded its footprint to include production locations in the key North American states of Washington, Nevada and California. It actively seeks expansion opportunities worldwide.

We seek Safe Harbor.